Table 2.
The results of HIFU followed by USg-D&C comparison between CSP-I and CSP-II group
| Characteristics | CSP-I(n = 101) | CSP-II(n = 52) | p value |
|---|---|---|---|
| HIFU treatment | |||
| Total treatment time (min) | 73 (52- 147) | 96 (67-153) | 0.038 |
| Sonication time (second) | 583 (426-716) | 601 (469-798) | 0.217 |
| Sonication power(W) | 367 (350-400) | 388 (350-400) | 0.862 |
| USg-D&C | |||
| USg-D&C time (min) | 29 (20-49) | 45 (25-70) | 0.037 |
| Median blood loss (ml) | 39 (15-100) | 65 (30-210) | 0.021 |
| Post-treatment of β-HCG (mIU/ml) | 13,852.38 (90.5-24,727) | 9368.6 (56-26,825) | 0.571 |
| Time of hospital stay (days) | 7.07 ± 1.83 | 7.18 ± 1.72 | 0.620 |
| Vaginal bleeding of post-treatment (day) | 15.3 ± 3.6 | 16.1 ± 4.3 | 0.821 |
| Time for β-HCG return to normalization (day) | 26.08 ± 5.02 | 28.03 ± 4.99 | 0.652 |
| Recovered of menstruation (day) | 38.22 ± 6.15 | 36.16 ± 5.57 | 0.471 |
Total treatment time, sonication time, sonication power, USg- D&C time, median blood losses and post-treatment of β-HCG are listed as medians